The Brain-Mapping Gold Rush Has a $8.6 Trillion Problem

The brain-mapping field has a number it does not want you to calculate.

Here is what the field actually does: connectomics — the effort to map every neuron and every synapse in a brain — has spent two decades driving down the cost of seeing individual neurons. The price per neuron has fallen from roughly $16,500 in the 1980s, for the original map of a tiny worm's nervous system, to about $100 today for small organisms like fruit fly larvae, according to a review published by Asimov Press in February. That is a collapse in cost, and it has made something that looked impossible 20 years ago look merely improbable.

The number nobody in the field wants you to calculate: 86 billion. That is approximately how many neurons are in a human brain, per the State of Brain Emulation Report 2025, a 175-page technical assessment published on arXiv last October. At $100 per neuron — the same rate that works for fruit flies — a complete human connectome would cost about $8.6 trillion. That is roughly 85 percent of global GDP.

The tweet that went viral last week, from tech and science curator Kol Tregaskes, described an MIT researcher named Isaak Freeman as quitting his PhD to pursue full brain emulation via connectomics, with a claimed roadmap toward 50,000 H100 GPUs. The tweet, which gathered more than 600 likes, presented this as a straight line from worm to human.

It is not. The report Freeman co-authored is careful about this. It notes that whole-brain recording at single-neuron resolution has not yet been achieved in any organism. The most advanced ongoing projects — fruit fly larvae, portions of mouse cortex — involve hundreds of thousands to low millions of neurons. The jump to 86 billion is roughly six orders of magnitude, and cost curves that work beautifully at small scale do not automatically continue that descent at human scale.

Anders Sandberg, who co-authored the original 2008 whole-brain emulation roadmap that this new report updates, called the cost figures in the current report the most useful quantitative update he has seen in nearly two decades. That is praise from someone who has been tracking this field since before any of the current players existed.

Freeman is listed in the MIT Bradley Institute directory and his LinkedIn shows a stealth startup alongside his MIT education. There is no public announcement of what he is building, and the specific claims attributed to him in the tweet — the 50,000 H100 figure, the roadmap to human-scale connectomics — are not sourced in the tweet itself. Attempts to reach Freeman directly were not returned before publication.

The gap between where the field is and where its most enthusiastic proponents say it is going remains enormous. At current costs, a human connectome would consume roughly the GDP of Germany. Even if future automation drives costs down further — and the field has seen this kind of cost descent before — getting to the necessary precision for a whole brain at human scale is a different kind of problem than speeding up existing workflows for larval zebrafish.

The connectomics cost story is real. The $8.6 trillion number is real math, not hype. Whether it stays out of reach for decades or gets collapsed by the next generation of automation tools is a genuine open question. The tweet that made this story viral answered it with confidence. The report Freeman co-authored does not.